A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind ...
The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
Yavapai County will be part of the High Intensity Drug Trafficking Area program, which opens up federal resources to police ...
President Joe Biden and Vice President Kamala Harris have repeatedly touted on the campaign trail their efforts to lower drug ...
The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.
The FDA released its annual Pesticide Residue Monitoring Program Report for Fiscal Year 2022, summarizing findings from the ...
The federal 340B Drug Pricing Program was designed to encourage hospitals and clinics to provide low-income patients with ...
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
A device that could potentially allow blind people — even those born without the sense of sight — to see has received the U.S. Food and Drug Administration’s “breakthrough device ...